Ozan Yazıcı

28PUBLICATIONS
135CO-AUTHORS
Molecular targetsNeurogeneticsCancer therapy (excl. chemotherapy and radiation therapy)Nutrigenomics and personalised nutritionPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (28)

|Sep 19, 2025
Real-world comparison of cabozantinib and sunitinib in advanced non-clear cell renal cell carcinoma: A multicenter study by the Turkish Oncology Group.

Gökhan Şahin, Esmanur Kaplan Tüzün, Halil G Güzel

|Jul 03, 2025
Attenuated Form of Nijmegen Breakage Syndrome: Case Report of the Oldest Patient.

Sultan Kevser Gangal, Abdullah Sezer, Ozan Yazici

|Jun 07, 2025
Does lifestyle and physical activity redefine the paradigm in lung cancer management?

Enes Yeşilbaş, Ilgın Koç Kuş, Sıla Soylu Koçoğlu

|May 06, 2025
Splenic index score as a predictor of outcomes in metastatic non small cell lung cancer patients treated with immune checkpoint inhibitors.

Volkan Aslan, Atiye Cenay Karabörk Kılıç, Nigar Rustamova Cennet

|Feb 20, 2025
Prognostic Nutritional Index as a Biomarker in Metastatic Hormone-Sensitive Prostate Cancer: Impact on Survival and Treatment Optimization.

Muhammet Bekir Hacioglu, Ahmet Kucukarda, Ivo Gokmen

|Jul 20, 2024
A propensity score-matched comparison of neoadjuvant chemoradiotherapy with cisplatin-5FU and carboplatin-paclitaxel in locally advanced esophageal squamous cell carcinoma: A Turkish oncology group study.

Fatih Gürler, Fatih Tay, Zehra Sucuoğlu İşleyen

Pageof 5

Frequent Collaborators

18 joint publications

Osman Sutcuoglu

17 joint publications

Nuriye Ozdemir

14 joint publications

Ahmet Ozet

8 joint publications

Fatih Gürler